UF Department of Radiation Oncology Praises Single-Use Scopes

Performing Procedures

University Touts Transition to Single-Use Rhinolaryngoscopes

"The COVID-19 pandemic has forced us all to take a look at how we balance careful infection control with fiscal and environmental responsibility."

The University of Florida recently transitioned to single-use rhinolaryngoscopes to diagnose and treat head and neck cancers.

The university’s radiation oncology department cited improved image quality and infection control among the reasons for the switch.

The UF Department of Radiation Oncology now uses the Ambu aScope 4 RhinoLaryngo for its patients, according to the university’s website.

“The COVID-19 pandemic has forced us all to take a look at how we balance careful infection control with fiscal and environmental responsibility,” Dr. Kathryn Hitchcock, a physician and assistant professor, said in the online statement.  “Once we saw the excellent clarity of the images provided by these devices, we knew they were the answer.”

The oncology department says the aScope RhinoLaryngo increases comfort and safety for patients during rhinolaryngoscopy. It's a small, flexible fiber-optic tube used to examine a patient’s airway and throat. Images and videos captured during procedures are then used by doctors to help with diagnosis and treatment planning.

Quality images can help identify head and neck cancers, and early detection of those cancers leads to improved survival rates and quality of life.

UF's announcement — released independent of Ambu — underscored its need for quality diagnostic equipment with statistics about the prevalence of head and neck cancers. Based on the most current data available from GLOBOCAN, new instances of head and neck cancers make the grouping the seventh most common cancer worldwide. Head and neck cancers include cancers of the oral cavity, pharynx, larynx, paranasal sinuses and nasal cavity, and salivary glands.

The Ambu scopes also help satisfy the university’s goals in terms of environmental responsibility with “a clear plan for keeping these materials out of landfills," university officials said.

Once used, the disposable devices are transported to specialized facilities where they are disassembled and converted to raw materials and energy.

Physicians at multiple academic hospitals across the U.S. scored the Ambu single-use rhinolaryngoscope superior in setup and convenience and better overall than reusable competitors. Those findings were detailed in a recent study published in Laryngoscope Investigative Otolaryngology.

The Ambu scope was found to be comparable to reusables in ergonomics and maneuverability and more cost effective, with no repairs or reprocessing needed for the same types of procedures.

More ENT Articles
Quantifying Infection Risk and Cost-Effectiveness in Bronchoscopy
Value-Based Care
The total cost per use of a single-use bronchoscope is 12 percent less than for a reusable bronchoscope, according to a new study. Single-use bronchoscopes also help significantly reduce infection risk, further decreasing potential costs per procedure.
Does Microbial Testing Make Financial Sense?
Value-Based Care
U.S. multisociety guidelines have no preferred recommendation for testing the adequate reprocessing of endoscopes. Microbial testing is timely and costly but, given the cost associated with transmitting an infection, is the time and money worth it?
More From Single-Use Endoscopy
Looking for a combination of teaching modes that will produce well-rounded bronchoscopists

Best Practices

A better understanding of how bronchoscopy is supervised could improve how bronchoscopy is taught, researchers write in a study of how attending pulmonologists teach fellows.

Sterile processing is only one field hard hit in the current labor market

Preventing Infection

There are multiple reasons why it’s so hard to find sterile processing technicians, nurses, and a variety of other workers these days. The Beyond Clean podcast explores what’s fueling the current challenges.

Routine bronchoscopy.

Preventing Infection

Dr. Ali Sadoughi, an interventional pulmonologist and critical care specialist at Montefiore Medical Center in New York, reacts to the updated safety communication from the FDA about reusable bronchoscopes.